The laboratory and clinical assessment of an isothiazole thiosemicarbazone (M 2 b 7714) against pox viruses.
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D009174:Mycoplasma / Q000187:drug effects; D011212:Poxviridae / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D012899:Smallpox / Q000188:drug therapy / Q000517:prevention & control; D013882:Thiosemicarbazones / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D014780:Viruses / Q000187:drug effects
D000998:Antiviral Agents; D013882:Thiosemicarbazones